Journal Article10.1002/ANIE.198205671
Basic Principles of the CIP-System and Proposals for a Revision†
Vladlmir Prelog,Günter Helmchen +1 more
569
TL;DR: From Configurational Notation of Stereoisomers to the Conceptual Basis of Stereo Chemistry as mentioned in this paper is the title of a lecture [V. Prelog, ACS Symp. Ser. No. 12 (1975) 179] in which the chronologically and alphabetically third member of the CIP-triumvirate discusses the history of the system.
read more
Abstract: “From Configurational Notation of Stereoisomers to the Conceptual Basis of Stereochemistry” is the title of a lecture [V. Prelog, ACS Symp. Ser. No. 12 (1975) 179] in which the chronologically and alphabetically third member of the CIP-triumvirate discusses the history of the CIP-system. The experience accumulated in the meantime, particularly the efforts to teach computers to use the system as described in 1966 by Cahn, Ingold and Prelog, has shown that certain of its aspects must be more strictly formulated and others modified. Questions dealing with stereoisomers (and stereotopicity), which previously have been treated predominantly in a pragmatic manner, are now discussed in a systematic way.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Update 1 of: Enantioselective enzymatic desymmetrizations in organic synthesis.
TL;DR: This is a Chemical Reviews Perennial Review of Enantioselective Enzymatic Desymmetrizations in Organic Synthesis.
Chirality–helicity of cumulenes: A non‐scalar charge density derived perspective
TL;DR: In this article , the presence of helical character and chirality using a vector-based charge density perspective instead of energetic or structural measures was investigated for α,ωdisubstituted [4]cumulenes as the end groups are torsioned.
Modern pharmaceutical drugs featuring aliphatic fluorine-containing groups
Jianlin Han,Alicja Wzorek,Taizo Ono,Karel Klika,Vadim Soloshonok,Jianlin Han,Alicja Wzorek,Taizo Ono,Karel Klika,Vadim Soloshonok +9 more
Abstract: This review profiles ten marketed pharmaceuticals approved by the US Food and Drug Agency within the last five years that feature aliphatic fluorination – a key structural feature pivotal to their biological activity. These include ivosidenib, developed for the treatment of acute myeloid leukemia and cholangiocarcinoma (bile duct cancer); ubrogepant, approved for the acute treatment of migraines; asciminib, prescribed for the treatment of chronic myeloid leukemia in the chronic phase; omaveloxolone, used in the treatment of Friedreich’s ataxia, a rare genetic disorder causing progressive damage to the spinal cord, peripheral nerves, and brain; flurpiridaz (18F), a radioactive diagnostic agent for myocardial perfusion imaging by positron emission tomography; upadacitinib, designed to address several inflammatory and autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn’s disease, ankylosing spondylitis, and non-radiographic axial spondyloarthritis; tezacaftor, approved for the treatment of cystic fibrosis as an effective remedy; alpelisib, prescribed for the treatment of breast cancer, effectively inhibiting tumor growth and abnormal cell proliferation; pretomanid, used in combination therapies for the treatment of extensively drug-resistant and multi-drug-resistant tuberculosis; and atogepant, approved for the preventive treatment of migraines in adults, targeting both episodic and chronic migraines. Molecules featuring aliphatic fluorination present challenges due to higher production costs and the complexity of predicting their biological profiles. However, the undeniable medicinal benefits of aliphatic fluorination invigorate this area of research, paving the way for the development of more innovative drugs to enter the pharmaceutical market. Beyond the incorporation of aliphatic fluorine atoms, six of the pharmaceuticals discussed in this review feature residues of amino acids or their derivatives as pivotal structural design elements. Another characteristic shared by all these drugs is their chirality, with each molecule possessing between one and six stereogenic carbons. Special attention should be directed toward the phenomenon of self-disproportionation of enantiomers (SDE), a behavior observed in enantiomerically enriched compounds. The SDE properties of chiral drugs, particularly those containing fluorine and/or amino acid residues, represent a vital public safety concern, necessitating rigorous evaluation of enantiomeric purity. Additionally, caution should be exercised in light of growing public concerns over the potential harmful effects of fluorine on human health. Since fluoride is recognized as the final metabolite of organic fluorinated compounds, patients prescribed fluorine-containing drugs should consult their physicians about non-fluorinated alternatives where available or take steps to limit fluoride exposure from other sources, such as fluoridated water and industrially produced foods treated with fluorinated agrochemicals. Despite these concerns, it remains an undeniable fact that fluorine-containing drugs are indispensable in modern medicine. They provide life-saving treatments, improve quality of life, and drive medical innovation addressing urgent health challenges and laying the foundation for future advancements in healthcare.
Validating computer simulations of enantioselective catalysis; reproducing the large steric and entropic contributions in Candida Antarctica lipase B
Patrick Schopf,Arieh Warshel +1 more
TL;DR: The prospect for computer‐aided refinement of stereoselective enzymes is further validated by simulating the ester hydrolysis by the wild‐type and mutants of CalB, focusing on the challenge of dealing with strong steric effects and entropic contributions.
References
Specification of Molecular Chirality
TL;DR: In this article, the topological analysis of chiral molecular models has been extended to deal with organic-chemical conformations, and, on the other hand, with inorganic-chemical configurations to ligancy six.
1.7K
Description of steric relationships across single bonds
W. Klyne,Vladimir Prelog +1 more
TL;DR: In this article, the authors propose an approach to bezeichnungen fur partielle Konformationen (Konstellationen) abgeleitet.
661
Unusually High Barriers to Rotation Involving the Tetrahedral Carbon Atom
TL;DR: In this article, the authors considered derivatives of triptycene and fluorene whose barriers to rotation were of the order of 30 kcal/mol, and showed that the barrier to rotation is high enough to give rise to rotamers.
126